{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:45:34Z","timestamp":1790005534496,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T00:00:00Z","timestamp":1640822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R35GM119839\\u201301"],"award-info":[{"award-number":["1R35GM119839\\u201301"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005496","name":"American Foundation for Pharmaceutical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009612","name":"Oregon State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"PhRMA Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.tranon.2021.101336","type":"journal-article","created":{"date-parts":[[2022,1,2]],"date-time":"2022-01-02T04:52:27Z","timestamp":1641099147000},"page":"101336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Development of a G2\/M arrest high-throughput screening method identifies potent radiosensitizers"],"prefix":"10.1016","volume":"16","author":[{"given":"Madeleine","family":"Landry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunseo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"DuRoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conroy","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2021.101336_bib0001","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1158\/1078-0432.CCR-18-2466","article-title":"Clinical Development of Novel Drug-Radiotherapy Combinations","volume":"25","author":"Ahmad","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2021.101336_bib0002","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41575-019-0247-2","article-title":"Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers","volume":"17","author":"Buckley","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tranon.2021.101336_bib0003","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrclinonc.2016.79","article-title":"Clinical development of new drug\u2013radiotherapy combinations","volume":"13","author":"Sharma","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tranon.2021.101336_bib0004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2020.03.047","article-title":"Dihydroouabain, a novel radiosensitizer for cervical cancer identified by automated high-throughput screening","volume":"148","author":"Li","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.tranon.2021.101336_bib0005","doi-asserted-by":"crossref","first-page":"E619","DOI":"10.1016\/j.ijrobp.2017.06.2094","article-title":"Ro90-7501 Is Identified As a Radiosensitizer By High Throughput Screening","volume":"99","author":"Tamari","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.tranon.2021.101336_bib0006","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1535-7163.MCT-14-0765","article-title":"Identification of Novel Radiosensitizers in a High-Throughput, Cell-Based Screen for DSB Repair Inhibitors","volume":"14","author":"Goglia","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tranon.2021.101336_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2020.100082","article-title":"Low Dose Novel PARP-PI3K Inhibition via Nanoformulation Improves Colorectal Cancer Immuno-Radiotherapy","author":"Landry","year":"2020","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.tranon.2021.101336_bib0008","series-title":"Radiobiology for the Radiologist","article-title":"Radiobiology for the Radiologist","author":"Hall","year":"2012"},{"key":"10.1016\/j.tranon.2021.101336_bib0009","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncponc0714","article-title":"The concurrent chemoradiation paradigm\u2014general principles","volume":"4","author":"Seiwert","year":"2007","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tranon.2021.101336_bib0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/labinvest.2017.13","article-title":"Blue intensity matters for cell cycle profiling in fluorescence DAPI-stained images","volume":"97","author":"Ferro","year":"2017","journal-title":"Lab. Invest."},{"key":"10.1016\/j.tranon.2021.101336_bib0011","doi-asserted-by":"crossref","first-page":"11261","DOI":"10.1038\/s41598-017-11508-2","article-title":"Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential","volume":"7","author":"Lo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2021.101336_bib0012","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nprot.2015.016","article-title":"Cell cycle staging of individual cells by fluorescence microscopy","volume":"10","author":"Roukos","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tranon.2021.101336_bib0013","series-title":"Assay GuidanceManual","article-title":"Advanced Assay Development Guidelines for Image-Based High Content Screening and Analysis","author":"Bray","year":"2004"},{"key":"10.1016\/j.tranon.2021.101336_bib0014","unstructured":"NCATS Inxight: drugs-PROFLAVINE, 2021."},{"key":"10.1016\/j.tranon.2021.101336_bib0015","doi-asserted-by":"crossref","first-page":"11166","DOI":"10.1021\/jp905765c","article-title":"Stacking Interactions and DNA Intercalation","volume":"113","author":"Li","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.tranon.2021.101336_bib0016","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1098\/rspb.1922.0025","article-title":"Relationships between Antiseptic Action and Chemical Constitution with Special Reference to Compounds of the Pyridine, Quinoline, Acridine and Phenazine Series","volume":"93","author":"Browning","year":"1922","journal-title":"Proc. R. Soc. Lond. Ser. B"},{"key":"10.1016\/j.tranon.2021.101336_bib0017","first-page":"2541","article-title":"DNA-intercalating drugs activate p53 transcriptional responses without evidence of DNA-damage signaling","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2021.101336_bib0018","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41598-017-02736-7","article-title":"The role of flavin-containing enzymes in mitochondrial membrane hyperpolarization and ROS production in respiring Saccharomyces cerevisiae cells under heat-shock conditions","volume":"7","author":"Fedoseeva","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2021.101336_bib0019","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jphotobiol.2017.06.014","article-title":"Blue light induced reactive oxygen species from flavin mononucleotide and flavin adenine dinucleotide on lethality of HeLa cells","volume":"173","author":"Yang","year":"2017","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.tranon.2021.101336_bib0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3892\/ol.2015.3206","article-title":"Proflavin suppresses the growth of human osteosarcoma MG63 cells through apoptosis and autophagy","volume":"10","author":"Zhang","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tranon.2021.101336_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-0963-7","article-title":"A comprehensive survey of the mutagenic impact of common cancer cytotoxics","volume":"17","author":"Szikriszt","year":"2016","journal-title":"Genome Biology"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321003272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321003272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:28:23Z","timestamp":1778833703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523321003272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":21,"alternative-id":["S1936523321003272"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101336","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a G2\/M arrest high-throughput screening method identifies potent radiosensitizers","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101336"}}